Publications by authors named "Jennifer Sheng"

Claim this Profile
T
The Impact of Baseline Sleep as a Potential Moderator of Weight Loss Intervention in Breast Cancer Survivors: Results From the POWER-Remote Trial.
Jennifer Y Sheng, Ruizhe Chen, Gary L Rosner, Claire F Snyder, Lawrence J Appel

Obesity (Silver Spring)· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exposure-Response Relationships for Axatilimab in Patients with Chronic Graft-Versus-Host Disease.
Yan-Ou Yang, Alina Volkova, Victor Sokolov, Xing Liu, Cristina Leon, Jennifer Sheng

Clin Pharmacol Ther· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combined technology-enhanced home exercise and acupressure (TEHEplus) program on symptoms among cancer patients receiving immunotherapy: a feasibility study.
Nada Lukkahatai, Chitchanok Benjasirisan, Aomei Shen, Junxin Li, Sarah Allgood, Jennifer Y Sheng

BMC Cancer· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advancing drug development with "Fit-for-Purpose" modeling informed approaches.
Jennifer Sheng, Tongli Zhang

J Pharmacokinet Pharmacodyn· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Effects of Post-diagnosis Recreational Aerobic Exercise among Breast Cancer Survivors: A Systematic Review/Meta-Analysis.
Oliver W A Wilson, Charles E Matthews, Kaitlyn M Wojcik, Yelena N Tarasenko, Gisela Butera, Jennifer Y Sheng

Cancer Epidemiol Biomarkers Prev· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Itraconazole or Rifampin on Zilurgisertib Pharmacokinetics When Administered Orally in Healthy Participants.
Yan-Ou Yang, Xiaohua Gong, Phillip Wang, Xiang Liu, Jay Getsy, Jennifer Sheng

Clin Pharmacol Drug Dev· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluating the Impact of Weekly Physical Performance Reports on Daily Physical Activity and Symptoms Among Cancer Survivors: Secondary Analysis of a Randomized Controlled Trial.
Mingfang Li, Chitchanok Benjasirisan, Jingyu Zhang, Jennifer Yeong-Shin Sheng, Junxin Li

Cancers (Basel)· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Comparison of In-Person and Telehealth Personalized Exercise Programs for Cancer Survivors: A Secondary Data Analysis.
Nada Lukkahatai, Gyumin Han, Chitchanok Benjasirisan, Jongmin Park, Hejingzi Monica Jia, Jennifer Y Sheng

Cancers (Basel)· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of cardiovascular risk factors on cancer progression: a prospective study in female breast cancer survivors.
Xinyi Feng, Zhengyi Deng, Michelle S McCullough, Betty J May, Erica Selznick, Jennifer Y Sheng

Breast Cancer Res Treat· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Model-Informed Immunogenicity Assessment of Nivolumab as Monotherapy and in Combination with Ipilimumab.
Yue Zhao, Li Li, Jessica Ma, Amit Roy, Akintunde Bello, Jennifer Sheng

AAPS J· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Semimechanistic Population PK/PD Modeling of Axatilimab in Healthy Participants and Patients With Solid Tumors or Chronic Graft-Versus-Host Disease.
Yan-Ou Yang, Victor Sokolov, Alina Volkova, Xing Liu, Cristina Leon, Jennifer Sheng

Clin Pharmacol Ther· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Healthcare provider perspectives on a clinical decision tool to support individualized exercise prescriptions and discussions for breast cancer survivors.
Jinani Jayasekera, Oliver W A Wilson, Kaitlyn M Wojcik, Eleanor M Kerr, Rachelle Brick, Jennifer Yeong-Shin Sheng

J Cancer Surviv· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics of Zilurgisertib With and Without Food from Single and Multiple Ascending Dose Phase 1 Studies in Healthy Adults.
Yan-Ou Yang, Xiaohua Gong, Jay Getsy, Phillip Wang, Xiang Liu, Jennifer Sheng

Eur J Drug Metab Pharmacokinet· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Factors associated with weight gain in pre- and post-menopausal women receiving adjuvant endocrine therapy for breast cancer.
Anna-Carson Rimer Uhelski, Amanda L Blackford, Jennifer Y Sheng, Claire Snyder, Jennifer Lehman

J Cancer Surviv· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The challenge of weight gain in hormone receptor-positive breast cancer.
Terrence C Tsou, Avonne Connor, Jennifer Y Sheng

Oncoscience· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploring the links of skeletal muscle mitochondrial oxidative capacity, physical functionality, and mental well-being of cancer survivors.
Stephen G Gonsalves, Leorey N Saligan, Christopher M Bergeron, Philip R Lee, Kenneth W Fishbein, Jennifer Yeong-Shin Sheng

Sci Rep· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Feasibility of Symptom Monitoring During the First Year of Endocrine Therapy for Early Breast Cancer Using Patient-Reported Outcomes Collected via Smartphone App.
Karen Lisa Smith, Hua-Ling Tsai, David Lim, Chenguang Wang, Raquel Nunes, Jennifer Y Sheng

JCO Oncol Pract· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Feasibility of DNA Methylation Age as a Biomarker of Symptoms and Resilience among Cancer Survivors with Multiple Chronic Conditions.
Nada Lukkahatai, Jongmin Park, Hejingzi Monica Jia, Daniel Martin, Junxin Li, Jennifer Yeong-Shin Sheng

Biomedicines· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Understanding the Challenges Faced by Esophageal and Gastroesophageal Junction Cancer Survivors.
Erin McGillivray, Rishi Jain, Chethan Ramamurthy, Jennifer Y Sheng, Evgenia Granina

J Patient Exp· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluating potential overuse of surveillance care in cancer survivors.
Jennifer Y Sheng, Claire F Snyder, Katherine C Smith, Jennifer DeSanto, Nancy Mayonado

Cancer Med· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Changing the drug development and therapeutic paradigm with biologic drug combinations and bispecifics: How to choose between these two approaches?
Songmao Zheng, Rodney Prell, Jennifer Sheng, Yow-Ming Wang, Lora Hamuro

Clin Transl Sci· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical interventions to break the obesity and cancer link: a narrative review.
Nakul J Bhardwaj, Kacey Chae, Jennifer Y Sheng, Hsin-Chieh Yeh

Cancer Metastasis Rev· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Weight Gain after Hormone Receptor-Positive Breast Cancer.
Archita Goyal, Gabrielle E Milner, Ashley Cimino-Mathews, Kala Visvanathan, Antonio C Wolff, Jennifer Y Sheng

Curr Oncol· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of hyperprogression versus the natural course of disease development with nivolumab with or without ipilimumab versus placebo in phase III, randomized, controlled trials.
Yoon-Koo Kang, Martin Reck, Paul Nghiem, Yan Feng, Gregory Plautz, Jennifer Sheng

J Immunother Cancer· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of treatment-emergent symptoms identified by patient-reported outcomes with adjuvant endocrine therapy discontinuation.
Karen Lisa Smith, Neha Verma, Amanda L Blackford, Jennifer Lehman, Kelly Westbrook, Jennifer Y Sheng

NPJ Breast Cancer· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis